DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Influenza B Infections - Pipeline Insights, 2017" drug pipelines to their offering.
Influenza B Infections - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Influenza B Infections. This report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Influenza B Infections.
This report also assesses the Influenza B Infections therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
- The report provides competitive pipeline landscape of Influenza B Infections
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Influenza B Infections pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Influenza B Infections and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Key Topics Covered:
- Influenza B Infections Overview
- Influenza B Infections Pipeline Therapeutics
- Influenza B Infections Therapeutics under Development by Companies
- Influenza B Infections Filed and Phase III Products
- Influenza B Infections Phase II Products
- Influenza B Infections Phase I and IND Filed Products
- Influenza B Infections Discovery and Pre-Clinical Stage Products
- Drug Candidate Profiles
- Influenza B Infections - Therapeutics Assessment
- Companies Involved in Therapeutics Development for Influenza B Infections
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/tgw4qr/influenza_b